Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Medical cannabis compound alleviates nightmares associated with PTSD

5

Aug 2026

Medical cannabis compound alleviates nightmares associated with PTSD

Nightmares are among the most agonizing symptoms of post-traumatic stress disorder (PTSD) – a condition that can develop after exposure to severe traumatic experiences, such as disasters, serious accidents, acts of violence, or wartime experiences. Individuals affected relive the events intensely at night, as if they were real, time and time again.

For students, an early social media account may come with a lasting classroom cost

5

Aug 2026

For students, an early social media account may come with a lasting classroom cost

Researchers linked retrospective digital-habit surveys from 5,227 northern Italian students with standardized test records spanning grades 2–10, including 4,545 students in the principal longitudinal analysis. Students who opened social media accounts in grades 6 or 7 had lower later Italian and mathematics scores than matched students who waited until grade 9 or later, although residual confounding cannot be excluded.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.